The impact of genetic factors on the response to migraine therapy.

doi:10.1515/revneuro-2024-0045

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The impact of genetic factors on the response to migraine therapy.

Reviews in the neurosciences - 28 Oct 2024

Tsirelis Daniil, Tsekouras Alexandros, Stamati Polyxeni, Liampas Ioannis, Zoupa Elli, Dastamani Metaxia, Tsouris Zisis, Papadimitriou Anastasios, Dardiotis Efthimios, Siokas Vasileios

Abstract excerpt

Migraine is a multidimensional disease affecting a large portion of the human population presenting with a variety of symptoms. In the era of personalized medicine, successful migraine treatment presents a challenge, as several studies have shown the impact of a patient's genetic profile on therapy response. However, with the emergence of contemporary treatment options, there is promise for improved outcomes. A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Migraine Disorders
Share to Pharmacogenetics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed

Identifiers

PMID: 38856190
DOI: 10.1515/revneuro-2024-0045

Provenance

PubMed metadata and Literature Corpus relationships.